Resultado de búsqueda
Hace 4 días · Future Pak increases its acquisition offer for Vanda Pharmaceuticals, offering contingent value rights and a cash consideration of $7.75 per share. Read more here.
Hace 4 días · May 7 (Reuters) - Privately held contract manufacturer Future Pak said on Tuesday it will sweeten its buyout offer for Vanda Pharmaceuticals to include contingent value rights, in addition to the...
Hace 1 día · View all Vandal skins in Valorant here featuring from alpha version to the newest release skin and price here.
Hace 4 días · WASHINGTON, May 7, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that it has received a revised unsolicited proposal from Future Pak,...
Hace 4 días · WIXOM, Mich., May 07, 2024 -- ( BUSINESS WIRE )--Future Pak LLC ("Future Pak") confirms it increased its offer for all outstanding shares of common stock of Vanda Pharmaceuticals ("Vanda" or "the...
Hace 4 días · WASHINGTON, May 7, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that it has received a revised unsolicited proposal from Future Pak, LLC ("Future Pak") to acquire the Company.
Hace 4 días · 1 Analyst. VNDA Stock Overview. Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. About the company. Rewards. Trading at 96.4% below our estimate of its fair value. Earnings are forecast to grow 2.39% per year. Risk Analysis.
